The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

LYEL FINANCIAL STATEMENTS

Lyell Immunopharma Inc — balance sheet, income statement and cash flow trends

LYELLyell Immunopharma Inc

🇺🇸 USA · NASDAQ · Healthcare · Biotechnology

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
-200 M0202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue27 K $Gross Profit-2.3 M $ · -8537%Operating Income-192.1 M $ · -711330%Pre-tax Income-248.5 M $ · -920285%Net Income to Owners-248.5 M $ · -920285%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue27 K $-55.0%
Gross Profit-2.3 M $-3,941.7%
Operating Income-192.1 M $—
EBITDA-239 M $—
Net Income to Owners-248.5 M $—

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
0500 M1 B202120222023202420252026

Capital Structure

Q2 2026
Total Assets311.2 M
  • Equity233.8 M $75%
  • Current Liabilities39.9 M $13%
  • Long-term Liabilities37.5 M $12%

Key Figures

YoY change
Total Assets311.2 M $-19.3%
Total Liabilities77.3 M $-10.6%
Total Equity233.8 M $-21.8%
Cash & ST Investments204.1 M $-26.3%
Total Debt36.9 M $-33.0%
Net Debt-36.1 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
-200 M-100 M0202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
-100 M-50 M0-133.3 M $Operating5 M $Investing102.5 M $Financing-25.8 M $Net Change

Key Figures

YoY change
Operating Cash Flow-133.3 M $—
Capital Expenditures711 K $+37.5%
Free Cash Flow-134 M $—
Dividends Paid——

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on LYEL

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 23, 26. This content is for informational purposes only and is not investment advice.